Style | Citing Format |
---|---|
MLA | Yadollahdamavandi S, et al.. "Atorvastatin Prevents the Neuron Loss in the Hippocampal Dentate Gyrus Region Through Its Anti-Oxidant and Anti-Apoptotic Activities." CNS and Neurological Disorders - Drug Targets, vol. 20, no. 1, 2021, pp. 76-86. |
APA | Yadollahdamavandi S, Sharifi ZN, Arani HZ, Jangholi E, Karimi A, Parsa Y, Movassaghi S (2021). Atorvastatin Prevents the Neuron Loss in the Hippocampal Dentate Gyrus Region Through Its Anti-Oxidant and Anti-Apoptotic Activities. CNS and Neurological Disorders - Drug Targets, 20(1), 76-86. |
Chicago | Yadollahdamavandi S, Sharifi ZN, Arani HZ, Jangholi E, Karimi A, Parsa Y, Movassaghi S. "Atorvastatin Prevents the Neuron Loss in the Hippocampal Dentate Gyrus Region Through Its Anti-Oxidant and Anti-Apoptotic Activities." CNS and Neurological Disorders - Drug Targets 20, no. 1 (2021): 76-86. |
Harvard | Yadollahdamavandi S et al. (2021) 'Atorvastatin Prevents the Neuron Loss in the Hippocampal Dentate Gyrus Region Through Its Anti-Oxidant and Anti-Apoptotic Activities', CNS and Neurological Disorders - Drug Targets, 20(1), pp. 76-86. |
Vancouver | Yadollahdamavandi S, Sharifi ZN, Arani HZ, Jangholi E, Karimi A, Parsa Y, et al.. Atorvastatin Prevents the Neuron Loss in the Hippocampal Dentate Gyrus Region Through Its Anti-Oxidant and Anti-Apoptotic Activities. CNS and Neurological Disorders - Drug Targets. 2021;20(1):76-86. |
BibTex | @article{ author = {Yadollahdamavandi S and Sharifi ZN and Arani HZ and Jangholi E and Karimi A and Parsa Y and Movassaghi S}, title = {Atorvastatin Prevents the Neuron Loss in the Hippocampal Dentate Gyrus Region Through Its Anti-Oxidant and Anti-Apoptotic Activities}, journal = {CNS and Neurological Disorders - Drug Targets}, volume = {20}, number = {1}, pages = {76-86}, year = {2021} } |
RIS | TY - JOUR AU - Yadollahdamavandi S AU - Sharifi ZN AU - Arani HZ AU - Jangholi E AU - Karimi A AU - Parsa Y AU - Movassaghi S TI - Atorvastatin Prevents the Neuron Loss in the Hippocampal Dentate Gyrus Region Through Its Anti-Oxidant and Anti-Apoptotic Activities JO - CNS and Neurological Disorders - Drug Targets VL - 20 IS - 1 SP - 76 EP - 86 PY - 2021 ER - |